FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 20:57:43 14/06/2024 BST | ||
| 9.02 EUR | +1.35% |
|
| Current month | +7.64% | ||
| 1 month | +2.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 9.02 | +1.35% |
| 13/06/24 | 8.9 | +1.48% |
| 12/06/24 | 8.77 | +3.06% |
| 11/06/24 | 8.51 | +1.67% |
| 10/06/24 | 8.37 | +2.83% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 08:57 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3D86 |
| ISIN | DE000MG3D866 |
| Date issued | 30/04/2024 |
| Strike | 184.7 $ |
| Maturity | Unlimited |
| Parity | 4.85 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.58 € |
|---|---|
| Lowest since issue | 7.66 € |
| Spread | 0.04 € |
| Spread % | 0.44% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.8
USD
Average target price
147
USD
Spread / Average Target
+6.64%
- Stock Market
- Certificates
- Certificat
